TO EVALUATE THE ADVERSE EFFECTS OF TEGAFUR URACIL AS METRONOMIC CHEMOTHERAPY IN PREVIOUSLY TREATED ADVANCED HEAD & NECK CANCER PATIENTS - A RETROSPECTIVE STUDY - Current Issue - IJSR